Profil
Christopher M.
Murphy is Chief Financial Officer at AnaptysBio, Inc. since 2026.
Formerly, Mr. Murphy was Treasurer, Chief Financial & Business Officer at Third Harmonic Bio, Inc. from 2024 to 2025.
From 2014 to 2020, Mr. Murphy was Group Vice President-Commercial Operations at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020.
Mr. Murphy completed undergraduate studies at the University of Notre Dame.
Aktive Positionen von Christopher Murphy
| Unternehmen | Position | Beginn |
|---|---|---|
| ANAPTYSBIO, INC. | Finanzdirektor/CFO | 11.05.2026 |
Ehemalige bekannte Positionen von Christopher Murphy
| Unternehmen | Position | Ende |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Finanzdirektor/CFO | 01.12.2025 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01.05.2020 |
Ausbildung von Christopher Murphy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
















